MedPath

Kerecis Ltd.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.kerecis.com

A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing

Early Phase 1
Completed
Conditions
Mucogingival Deformity - Insufficient Keratinized Tissue
Interventions
Device: Kerecis Oral™
Other: Free Gingival Graft
First Posted Date
2018-09-10
Last Posted Date
2018-09-13
Lead Sponsor
Kerecis Ltd.
Target Recruit Count
6
Registration Number
NCT03664401

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Not Applicable
Completed
Conditions
Healing Times
Punch Biopsy Wounds
Interventions
Device: Punch biopsies treated with MariGen Wound ECM dressing
Device: Punch biopsies treated with Oasis ECM dressing
First Posted Date
2013-08-06
Last Posted Date
2024-03-08
Lead Sponsor
Kerecis Ltd.
Target Recruit Count
81
Registration Number
NCT01917591
Locations
🇮🇸

Læknastofur Skipholti, Reykjavik, Iceland

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Not Applicable
Completed
Conditions
Diabetic Ulcers
Chronic Ulcer of Foot
Pressure Ulcers
Venous Ulcers
Trauma-related Wound
Interventions
Device: Marigen Wound Dressing
First Posted Date
2011-05-05
Last Posted Date
2017-03-03
Lead Sponsor
Kerecis Ltd.
Target Recruit Count
37
Registration Number
NCT01348581
Locations
🇮🇸

National University Hospital, Reykjavik, Iceland

© Copyright 2025. All Rights Reserved by MedPath